The renin-angiotensin system and its blockers
Texto
Documentos relacionados
Os elementos de estratégia são pensados para a realidade do Concelho de Beja inserido num mundo cada vez mais interligado. As áreas delimitadas pelas opções de intervenção são
The present study reports three cases of RAVF, including one case of a de novo idiopathic RAVF, which presented with hypertension and kidney and/or heart failure and describes
Background: The presence of anemia and renal dysfunction grants a bad prognosis for patients with heart failure and reduced ejection fraction (HFREF).. The impact on patients
Com efeito, a defesa dos conflitos que envolvem interesses supraindividuais e me- taindividuais (difusos, coletivos e individuais homogêneos), por meio da ação civil
Criteria - Studies that statistically compare survival, disease-free survival, morbidity and mortality associated with the procedure, and mortality associated with cancer in
The role of b-adrenergic blocking drugs in reducing morbidity and mortality in heart failure patients with functional class II and III has been consistently demonstra- ted recently
The- refore, digitalis is less frequently prescribed for patients with ischemic heart disease, and the angiotensin-con- verting enzyme inhibitors more frequently prescribed for
the distance walked during the six-minute walk test was recognized as an independent variable indicating mortality and morbidity in patients with class II and III heart failure..
